Lung toxicity in radioiodine therapy of thyroid carcinoma: development of a dose-rate method and dosimetric implications of the 80-mCi rule
Based on an extensive dataset analyzed by Benua et al., a whole-body retention threshold
of 2.96 GBq (80 mCi) at 48 h has been used to limit the radioactivity of 131I administered to …
of 2.96 GBq (80 mCi) at 48 h has been used to limit the radioactivity of 131I administered to …
Lung dosimetry for radioiodine treatment planning in the case of diffuse lung metastases
The lungs are the most frequent sites of distant metastasis in differentiated thyroid
carcinoma. Radioiodine treatment planning for these patients is usually performed following …
carcinoma. Radioiodine treatment planning for these patients is usually performed following …
Assessment of radioiodine clearance in patients with differentiated thyroid cancer
F Tabei, I Neshandar Asli… - Radiation protection …, 2012 - academic.oup.com
Radioiodine (131I iodide) has long been a safe, effective and widely used treatment in the
management of differentiated thyroid cancer (DTC). Concerns regarding stochastic …
management of differentiated thyroid cancer (DTC). Concerns regarding stochastic …
Thyroid Cancer: Radiation Safety Precautions in 131I Therapy Based on Actual Biokinetic Measurements
B Liu, W Peng, R Huang, R Tian, Y Zeng, A Kuang - Radiology, 2014 - pubs.rsna.org
Purpose To formulate radiation precautions for patients with thyroid cancer who are
undergoing thyroid hormone withdrawal–induced hypothyroidism and iodine 131 (131I) …
undergoing thyroid hormone withdrawal–induced hypothyroidism and iodine 131 (131I) …
The use of dosimetry in the treatment of differentiated thyroid cancer.
M Lassmann, H Hänscheid, FA Verburg… - The Quarterly Journal …, 2011 - europepmc.org
The standard treatment for the ablation of thyroid remnant tissue following surgery as well as
for the treatment of iodine avid metastases in patients suffering from differentiated thyroid …
for the treatment of iodine avid metastases in patients suffering from differentiated thyroid …
Radioactive body burden measurements in 131 iodine therapy for differentiated thyroid cancer: Effect of recombinant thyroid stimulating hormone in whole body 131 …
R Ravichandran, A Al Saadi… - World Journal of Nuclear …, 2014 - thieme-connect.com
Protocols in the management of differentiated thyroid cancer, recommend adequate thyroid
stimulating hormone (TSH) stimulation for radioactive 131 I administrations, both for imaging …
stimulating hormone (TSH) stimulation for radioactive 131 I administrations, both for imaging …
Physics aspects of setting up a multicenter clinical trial involving internal dosimetry of radioiodine treatment of differentiated thyroid cancer.
J Taprogge, F Leek, GD Flux - … of the Italian Association of Nuclear …, 2019 - europepmc.org
The field of molecular radiotherapy is expanding rapidly, with the advent of many new
radiotherapeutics for the treatment of common as well as for rare cancers. Treatment …
radiotherapeutics for the treatment of common as well as for rare cancers. Treatment …
Radiation dose assessment in radioiodine therapy. Dose-response relationships in differentiated thyroid carcinoma using quantitative scanning and PET
MEA O'Connell, MA Flower, PJ Hinton… - Radiotherapy and …, 1993 - Elsevier
Dose-response charts have been constructed to determine the tumouricidal dose for
differentiated thyroid carcinoma metastases and thus enable precise activities of radioiodine …
differentiated thyroid carcinoma metastases and thus enable precise activities of radioiodine …
Thyroid carcinoma with high levels of function: treatment with 131I
JC Sisson, JE Carey - Journal of Nuclear Medicine, 2001 - Soc Nuclear Med
In some patients with well-differentiated thyroid carcinoma, dosimetry is necessary to avoid
toxicity from therapy and to guide prescription of the administered activity of radioiodine …
toxicity from therapy and to guide prescription of the administered activity of radioiodine …
[PDF][PDF] Thyroid cancer dosimetry using clearance fitting
EE Furhang, SM Larson, P Buranapong… - Journal of Nuclear …, 1999 - Soc Nuclear Med
Since 1962, Memorial Sloan Kettering Cancer Center has used an individually optimized
dosimetry method for patients with thyroid carcinoma undergoing radioiodine therapy. This …
dosimetry method for patients with thyroid carcinoma undergoing radioiodine therapy. This …
Related searches
- lung toxicity dose rate
- dosimetric implications dose rate
- radioiodine therapy dose rate
- thyroid carcinoma dose rate
- lung toxicity dosimetric implications
- lung toxicity radioiodine therapy
- thyroid carcinoma radioiodine therapy
- dosimetric implications radioiodine therapy
- lung toxicity thyroid carcinoma
- thyroid carcinoma dosimetric implications
- 131i therapy thyroid cancer
- thyroid carcinoma treatment with 131i
- radioiodine therapy quantitative scanning
- thyroid carcinoma quantitative scanning
- thyroid carcinoma high levels
- pulmonary metastases thyroid cancer